As a world leader in pharmaceutical services, Almac delivers unrivalled polymorph, salt, co-crystal, and early crystallisation work programs designed to identify the most developable solid form of your API to help accelerate development to the clinic and minimise risk in any downstream activities.

Almac’s offerings include:

• Work programmes
• Solid state characterisation and chemical identification
• Development assessments
• Salt screening
• Co-crystal screening
• Polymorph and crystallisation screening

To find out more, view the brochure below.